Table S2.
Clinical features | Total | Mild XP-A | % | XP-A | % | XP-B | % | XP-C | % | XP-D | % | XP-E | % | XP-F | % | XP-G | % | XP-V | % | |
Total cases reported | 89 | 10 | 11 | 8 | 9 | 2 | 2 | 28 | 31 | 14 | 16 | 4 | 4 | 3 | 3 | 8 | 9 | 12 | 13 | |
Median age as of December 2014 | 35 | 17 | 45 | 14 | 24 | 56 | 23 | 19 | 55 | |||||||||||
Average ocular score (maximum 12) | 2 | 3 | 4 | 4 | 2 | 3 | 1 | 3 | 2 | |||||||||||
Maximum ocular score in group | 4 | 6 | 4 | 11 | 4 | 4 | 3 | 4 | 5 | |||||||||||
Photophobia | 3 | 30 | 6 | 75 | 0 | 0 | 20 | 71 | 12 | 86 | 3 | 75 | 2 | 67 | 3 | 38 | 9 | 75 | ||
Interpalpebral conjunctival melanosis | 8 | 80 | 5 | 63 | 0 | 0 | 21 | 75 | 1 | 7 | 0 | 0 | 0 | 0 | 2 | 25 | 2 | 17 | ||
Interpalpebral conjunctival melanosis with fair skin | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 1 | 7 | 0 | 0 | 0 | 0 | 1 | 13 | 1 | 8 | ||
Conjunctival injection | 0 | 0 | 5 | 63 | 1 | 50 | 20 | 71 | 2 | 14 | 3 | 75 | 0 | 0 | 4 | 50 | 3 | 25 | ||
Conjunctival corkscrew vessels | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 57 | 0 | 0 | 1 | 25 | 0 | 0 | 1 | 13 | 2 | 17 | ||
Pterygium | 6 | 60 | 3 | 38 | 1 | 50 | 14 | 50 | 7 | 50 | 3 | 75 | 0 | 0 | 1 | 13 | 1 | 8 | ||
Pingueculae < age 50 y | 2 | 20 | 0 | 0 | 0 | 0 | 9 | 32 | 3 | 21 | 0 | 0 | 0 | 0 | 2 | 25 | 5 | 42 | ||
Lagophthalmos/ectropion | 1 | 10 | 1 | 13 | 0 | 0 | 6 | 21 | 3 | 21 | 0 | 0 | 1 | 33 | 1 | 13 | 2 | 17 | ||
Keratopathy (corneal staining) | 1 | 10 | 1 | 13 | 2 | 100 | 9 | 32 | 2 | 14 | 0 | 0 | 1 | 33 | 2 | 25 | 1 | 8 | ||
Corneal scarring/neovascularization | 0 | 0 | 1 | 13 | 0 | 0 | 8 | 29 | 0 | 0 | 2 | 50 | 0 | 0 | 2 | 25 | 2 | 17 | ||
Ocular surface cancer | 0 | 0 | 3 | 38 | 1 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |